Home/Filings/4/0001171843-16-010595
4//SEC Filing

AKORN INC 4

Accession 0001171843-16-010595

CIK 0000003116operating

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 7:00 PM ET

Size

20.6 KB

Accession

0001171843-16-010595

Insider Transaction Report

Form 4
Period: 2016-06-07
KUTINSKY BRUCE
President, Consumer Health Div
Transactions
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2016-06-0742,000208,000 total
    Exercise: $5.43Common Stock (42,000 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2016-06-09208,0000 total
    Exercise: $5.43Common Stock (208,000 underlying)
  • Sale

    Common Stock

    2016-06-09$30.99/sh100,000$3,099,000249,695 total
  • Tax Payment

    Common Stock

    2016-06-09$30.80/sh86,436$2,662,229163,259 total
  • Sale

    Common Stock

    2016-06-07$31.43/sh42,000$1,320,06016,695 total
  • Exercise/Conversion

    Common Stock

    2016-06-09$6.62/sh+125,000$827,500349,695 total
  • Exercise/Conversion

    Common Stock

    2016-06-07$5.43/sh+42,000$228,06058,695 total
  • Exercise/Conversion

    Common Stock

    2016-06-09$5.43/sh+208,000$1,129,440224,695 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2016-06-09125,0000 total
    Exercise: $6.62Common Stock (125,000 underlying)
Footnotes (8)
  • [F1]Amount of Shares Beneficially Owned Following Reported Transaction includes 3,722 unvested shares subject to restricted stock awards and 54,973 shares owned outright. Amount of securities owned outright includes shares acquired through the reporting person's annual participation in the Employee Stock Purchase Plan in 2014 of 1,015 shares.
  • [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $31.25 to $31.60 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
  • [F3]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $30.68 to $31.44 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
  • [F4]Closing stock price as of June 9, 2016 as per Nasdaq.
  • [F5]These options vested in three installments on December 10, 2011, December 10, 2012 and December 10, 2013.
  • [F6]These options were fully vested and scheduled to expire if not exercised on or before December 10, 2015. However, due to legal restrictions under the securities laws, the options could not be exercised until June 2, 2016 and thus the expiration date was tolled until July 2, 2016.
  • [F7]These options vested in three installments on April 29, 2012, April 29, 2013 and April 29, 2014.
  • [F8]These options were fully vested and scheduled to expire if not exercised on or before April 29, 2016. However, due to legal restrictions under the securities laws, the options could not be exercised until June 2, 2016 and thus the expiration date was tolled until July 2, 2016.

Issuer

AKORN INC

CIK 0000003116

Entity typeoperating
IncorporatedLA

Related Parties

1
  • filerCIK 0000003116

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 7:00 PM ET
Size
20.6 KB